Immix Biopharma Inc.
IMMX | NASDAQ
$7.20
-$0.77 (-9.66%)
At close: Nov 4, 2026, 4:00 PM ET
$7.27
+$0.07 (+0.97%)
After-hours:
Nov 5, 2026, 4:27 PM ET
Fiscal Quarter Period Ending | Q2 2026 Jun 30, 2026 | Q1 2026 Mar 31, 2026 | Q4 2025 Dec 31, 2025 | Q3 2025 Sep 30, 2025 | Q2 2025 Jun 30, 2025 | Q1 2025 Mar 31, 2025 | Q4 2024 Dec 31, 2024 | Q3 2024 Sep 30, 2024 | Q2 2024 Jun 30, 2024 | Q1 2024 Mar 31, 2024 | Q4 2023 Dec 31, 2023 | Q3 2023 Sep 30, 2023 | Q2 2023 Jun 30, 2023 | Q1 2023 Mar 31, 2023 | Q4 2022 Dec 31, 2022 | Q3 2022 Sep 30, 2022 | Q2 2022 Jun 30, 2022 | Q1 2022 Mar 31, 2022 | Q4 2021 Dec 31, 2021 | Q3 2021 Sep 30, 2021 | Q2 2021 Jun 30, 2021 | Q1 2021 Mar 31, 2021 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Net Income | -11.56M | -10.09M | -10.69M | -7.59M | -6.62M | -4.54M | -4.81M | -7.15M | -4.41M | -5.33M | -5.16M | -4.34M | -3.6M | -2.5M | -3.8M | -1.54M | -1.56M | -1.33M | -22.76M | -403.27K | -208.64K | -1.02M |
Depreciation & Amortization | 130.88K | 130.77K | 90.63K | 134.86K | 79.84K | 59.18K | 41.34K | 25.91K | 24.3K | 23.85K | 3.08K | 1.38K | 506 | 505 | 566 | 566 | 383 | 620 | 620 | 620 | 20.35K | 608 |
Stock-Based Compensation | 978.14K | 575.57K | 570.8K | n/a | n/a | n/a | 705.65K | 733.81K | 637.85K | 943.26K | 1.05M | 737.33K | 447.66K | 329.92K | 230.09K | 213.19K | 115.71K | 65.07K | 122.15K | 61.86K | 30.72K | n/a |
Other Working Capital | -744.47K | -901.82K | -224.72K | 17.91K | 154.53K | -332.45K | 532.55K | 2.29M | -1.61M | 1.45M | 1.04M | -2.64M | -1.33M | -43.01K | -898.59K | 218.6K | 333.28K | -353.43K | -472.86K | 23.73K | 40.35K | 26.15K |
Other Non-Cash Items | -462.94K | 23.51K | n/a | 470.47K | 532.25K | 868.36K | n/a | n/a | n/a | n/a | n/a | 1.58M | n/a | n/a | n/a | n/a | n/a | n/a | 22.13M | 20.12K | -40.79K | 890.94K |
Deferred Income Tax | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Change in Working Capital | -824.58K | -470.34K | -1M | 1.07M | 700.7K | 1.93M | 2.59M | 2.35M | -1.51M | 537.1K | 1.42M | -1.06M | -365.3K | 75.61K | -334.75K | -141.2K | 899.62K | -228.47K | -609.16K | 269.91K | 40.35K | -141.34K |
Operating Cash Flow | -11.74M | -9.83M | -11.03M | -5.91M | -5.31M | -1.69M | -1.48M | -4.04M | -5.26M | -3.83M | -2.68M | -3.09M | -3.52M | -2.09M | -3.9M | -1.46M | -547.07K | -1.49M | -1.11M | -50.76K | -158.01K | -266.45K |
Capital Expenditures | -21.04K | -32.49K | -165.13K | -372.46K | -127.63K | -67.71K | -507.15K | -271.54K | -97.07K | -301.91K | -13.18K | -38.91K | -4 | -4 | -4 | -1 | -4 | 2 | 4 | n/a | n/a | -804 |
Cash Acquisitions | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Purchase of Investments | -4.55M | -7.77M | -6.48M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Sales Maturities Of Investments | 7.24M | 3M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Investing Acitivies | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Investing Cash Flow | 2.67M | -4.8M | -6.65M | -372.46K | -127.63K | -67.71K | -507.15K | -271.54K | -97.07K | -301.91K | -13.18K | -38.91K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -802 |
Debt Repayment | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -50K | n/a | n/a | n/a | 100K | 100K |
Common Stock Repurchased | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -44K | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Dividend Paid | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Financial Acitivies | 71.09K | n/a | n/a | -166.76K | n/a | n/a | n/a | n/a | n/a | 2.49K | 2.62K | -58.8K | -190.82K | 15K | 468.28K | n/a | n/a | n/a | n/a | -18.35K | -17.67K | n/a |
Financial Cash Flow | 155.28M | -37.56K | 95.67M | 10.61M | 1.11M | n/a | n/a | n/a | n/a | 15.95M | 586.69K | 10.07M | 4.69M | 118.92K | 424.28K | n/a | -105.96K | 2.91M | 18.72M | -18.35K | 82.33K | 65K |
Net Cash Flow | 146.24M | -14.68M | 77.98M | 4.31M | -4.28M | -1.76M | -2.01M | -4.28M | -5.34M | 11.81M | -2.07M | 6.93M | 1.19M | -1.97M | -3.48M | -1.49M | -658.33K | 1.42M | 17.61M | -72.61K | -70.19K | n/a |
Free Cash Flow | -11.76M | -9.86M | -11.19M | -6.28M | -5.44M | -1.75M | -1.98M | -4.31M | -5.35M | -4.13M | -2.69M | -3.13M | -3.52M | -2.09M | -3.9M | -1.46M | -547.07K | -1.49M | -1.11M | -50.76K | -158.01K | -267.25K |
Adj. Free Cash Flow | -12.73M | -10.44M | -11.77M | -6.28M | -5.44M | -1.75M | -2.69M | -5.04M | -5.99M | -5.07M | -3.74M | -3.86M | -3.96M | -2.42M | -4.13M | -1.68M | -662.78K | -1.56M | -1.24M | -112.62K | -188.73K | -267.25K |
Maintenance CapEx | -21.04K | -32.49K | -90.63K | -134.86K | -79.84K | -59.18K | -41.34K | -25.91K | -24.3K | -23.85K | -3.08K | -1.38K | -4 | -4 | -4 | -1 | -4 | -2 | -4 | n/a | n/a | -608 |
Growth CapEx | n/a | n/a | -74.5K | -237.6K | -47.8K | -8.53K | -465.82K | -245.64K | -72.78K | -278.06K | -10.1K | -37.53K | n/a | n/a | n/a | n/a | n/a | 4 | 8 | n/a | n/a | -196 |
Owner Earnings | -11.76M | -9.86M | -11.12M | -6.04M | -5.39M | -1.74M | -1.52M | -4.06M | -5.28M | -3.85M | -2.68M | -3.09M | -3.52M | -2.09M | -3.9M | -1.46M | -547.07K | -1.49M | -1.11M | -50.76K | -158.01K | -267.05K |
Add to Watchlist
Select watchlists to add or remove IMMX